Life Sciences

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

Share this post:

 

Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

More Life Sciences stories

Watson Health success story: Novant Health UVA Health System Culpeper Medical Center

Written by Watson Health | Value-Based Care, Video

Novant Health UVA Health System Culpeper Medical Center analyzed data to tackle their #1 cause of readmissions: sepsis. ...read more


Watson Health Success Story: Schneck Medical Center

Written by Watson Health | Value-Based Care, Video

Learn how Schneck Medical Center focused efforts to improve care for COPD patients, resulting in an 80 percent reduction in the unplanned COPD readmission rate and hundreds of thousands of dollars in savings. ...read more


Watson Health success story: AHMC Healthcare

Written by Watson Health | Value-Based Care, Video

Jon Aquino, Corporate Chief Quality and Vice Compliance Officer at AHMC Healthcare shares his experience with using Watson Health solutions to support quality improvement efforts in the sepsis patient population. ...read more